Alloy Therapeutics

Alloy Therapeutics, Inc. is a biotechnology ecosystem company based in Waltham, Massachusetts. Founded in 2017, Alloy focuses on empowering the scientific community to accelerate drug discovery and improve medicine development. The company combines scientific expertise with innovative technology platforms to provide accessible tools, services, and collaborative opportunities for therapeutic biologics discovery. Alloy offers a range of services, including high-velocity antibody discovery using proprietary transgenic mouse platforms, the Anticlastic™ antisense platform for developing oligonucleotide drug candidates, and next-generation cell therapy platforms based on induced pluripotent stem cells. The company also utilizes AI and machine learning to enhance its discovery capabilities. Alloy collaborates with pharmaceutical and biotech partners globally, including notable partnerships with Pfizer, Sanofi, and Takeda. With a team of over 100 scientists across various locations, Alloy is committed to fostering innovation and broad accessibility in drug discovery.

Research Lexington, United States ~107 employees Private · Series A

Work at Alloy Therapeutics in HR or recruiting? Claim this page

Employees
107
+7% in the 3 months to Jun 2025
Revenue / employee
$338K
Revenue ~$36.2M
Total funding
$182M
Last round Series A, Nov 2022
12-month attrition
23.8%
Tech: 79.6%
H1B filings, FY2026
4
Sponsors visas

Headcount trend

Alloy Therapeutics went from 101 employees in Jul 2023 to 107 in Jun 2025. Jan to Jun 2025: 15 people joined, 4 left.

Headcount data through Jun 2025

Funding rounds

Total funding$182M
Funding rounds3
Investors6
DateRoundMoney raisedNo.Investors
Nov 2022Series A$65M––
Oct 2022Series D$42M5
Apr 2021Series C$75M5

Org structure

Headcount by department

Other78
Operations12
Sales11
Finance2
Marketing1
HR1
Engineering1
Product1

Salaries at Alloy Therapeutics

All salaries

2 salary profiles in the US

Pay by level, gender and ethnicity

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering8

The department split adds up all the years listed above. FY2026 alone: 4 filings.

Peer reviews

Worked with someone at Alloy Therapeutics?

Anonymous peer reviews on OffTheRecord

Read or write a review

Hiring now

Similar companies

Alloy Therapeutics FAQ

How many employees does Alloy Therapeutics have?

Alloy Therapeutics has about 107 employees, up 7% over the 3 months to Jun 2025.

Does Alloy Therapeutics sponsor H1B visas?

Yes. Alloy Therapeutics filed 4 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

What is Alloy Therapeutics's revenue per employee?

Alloy Therapeutics makes about $338K in revenue per employee, based on $36.2M annual revenue and 107 employees.

How much does Alloy Therapeutics pay?

6figr has 2 salary profiles for Alloy Therapeutics in the US, with pay broken down by role, level, gender and ethnicity on the Alloy Therapeutics salaries page. See Alloy Therapeutics salaries

How much funding has Alloy Therapeutics raised?

Alloy Therapeutics has raised $182M in total funding; its latest round was Series A in Nov 2022.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.